Arcus Biosciences (RCUS) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Arcus Biosciences (RCUS) over the last 7 years, with Q3 2025 value amounting to -$1.27.
- Arcus Biosciences' EPS (Weighted Average and Diluted) fell 2700.0% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.44, marking a year-over-year decrease of 920.63%. This contributed to the annual value of -$3.14 for FY2024, which is 2431.43% up from last year.
- Latest data reveals that Arcus Biosciences reported EPS (Weighted Average and Diluted) of -$1.27 as of Q3 2025, which was down 2700.0% from -$1.14 recorded in Q1 2025.
- Arcus Biosciences' EPS (Weighted Average and Diluted)'s 5-year high stood at $3.99 during Q4 2021, with a 5-year trough of -$1.27 in Q3 2025.
- In the last 5 years, Arcus Biosciences' EPS (Weighted Average and Diluted) had a median value of -$1.01 in 2024 and averaged -$0.66.
- Data for Arcus Biosciences' EPS (Weighted Average and Diluted) shows a peak YoY increase of 55862.07% (in 2021) and a maximum YoY decrease of 380000.0% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Arcus Biosciences' EPS (Weighted Average and Diluted) stood at $3.99 in 2021, then tumbled by 123.31% to -$0.93 in 2022, then dropped by 16.13% to -$1.08 in 2023, then rose by 3.4% to -$1.04 in 2024, then dropped by 21.73% to -$1.27 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.27 for Q3 2025, versus -$1.14 for Q1 2025 and -$1.04 for Q4 2024.